A predictive test for personalization of anti-tumor treatment. This diagnostic tool is designed to assist in tailoring cancer treatment strategies to individual patient needs.
Manufactured by
Limoges Cedex, France
Oncomedics is a biotechnology company specialising in the personalisation of cancer treatments. We are developing in vitro diagnostic medical devices that provide decision support to practitioners (surgeons, pathologists and oncologists) in order to identify the most effective treatments to cure a patient. Founded in 2006 by Christophe Lautrette and Stéphanie Giraud, Oncomedics has its own laboratory and production unit in Limoges (Nouvelle-Aquitaine, France). Oncomedics has established numerous solid collaborations with clinical centres (AP-HP, HCL, Institut Bergonié), academic laboratories (Paris, Lyon, Marseille), pharmaceutical industries (Ipsen, Sanofi... ) and biotechnology companies (Oncodesign).
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 4 relevant products
Diatech Pharmacogenetics srl
Italy · 2 relevant products
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 6 relevant products
International Company for medical eq.
Egypt · 1 relevant product
TrustBio Corporation
Taiwan · 1 relevant product
Hahn-Schickard-Gesellschaft für angewandte Forschung e.V.
Germany · 2 relevant products
Eurobio-Scientific
United States · 1 relevant product
CheMOnitor Ltd.
Hungary · 2 relevant products
guangzhou biotron technolongy co.,ltd
China · 2 relevant products
APPOLON BIOTECK SAS
France · 1 relevant product
50 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 92 closest product alternatives
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Precision medicine test identifying optimal chemotherapy agents for individual tumors based on molecular characteristics. Guides targeted drug selection and improves treatment efficacy.
Diatech Pharmacogenetics srl · Italy
Molecular diagnostic testing for oncology patients to support faster diagnosis and identification of appropriate therapeutic options. Reduces turnaround time for molecular testing to enable faster clinical decision-making.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
In vitro diagnostic test for identifying genetic biomarkers that predict treatment response in cancer patients. Guides selection of targeted therapies and treatment protocols.
International Company for medical eq. · Egypt
Molecular diagnostic testing for cancer detection and monitoring.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Molecular diagnostic test providing precise tumor subtyping for improved treatment stratification. Supports personalized oncology management and therapeutic decision-making.
TrustBio Corporation · Taiwan
Molecular diagnostic tools for oncology applications. Supports precision diagnostics for cancer-related molecular analysis.
Hahn-Schickard-Gesellschaft für angewandte Forschung e.V. · Germany
Customized immunoassay and multi-omics diagnostic solutions leveraging microsystems technology and nanoponetechnology for rapid, precise disease detection. Enables development of epigenetic and molecular biomarker tests from concept through manufacturing, reducing turnaround time and complexity compared to conventional laboratory methods.
Eurobio-Scientific · United States
A prognostic genomic test for breast cancer that assesses individual cancer risk and treatment response. This molecular diagnostic helps guide clinical decision-making for breast cancer patients.
CheMOnitor Ltd. · Hungary
An in vitro diagnostic blood test designed to predict chemotherapy effectiveness in lung cancer patients at an early stage, before full treatment cycles are completed. The test analyzes N-glycan profiles using ultra-high resolution glycomics combined with AI-based data interpretation to provide oncologists with actionable treatment response predictions.
guangzhou biotron technolongy co.,ltd · China
Molecular diagnostic system tracking circulating tumor cell dynamics and nucleic acid markers to evaluate cancer treatment efficacy and guide therapeutic decisions.
APPOLON BIOTECK SAS · France
In vitro diagnostic devices for oncology applications focusing on genetic mutation detection and biomarker analysis. Supports clinical decision-making through comprehensive molecular profiling.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Molecular diagnostic test for monitoring therapeutic response and detecting minimal residual disease in cancer patients. Supports ongoing treatment optimization and prognosis assessment.
80 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products